India pharma giants in $4bn merger

Home › India pharma giants in $4bn merger

India's Sun Pharmaceutical agrees to acquire rival Ranbaxy - majority owned by Japan's Daiichi Sankyo - in an all-stock deal worth $4bn (2.4bn).

27.11	Interra adds Netflix VMAF video quality assessment support
27.11	Brightcove to be acquired by Bending Spoons
27.11	FOX, Disney capitalize on multiplatform TV footprint in October
27.11	Tele Columbus TV households down 40% YoY in 3Q 2024
27.11	'It's going to be hard': US firms race to get ahead of Trump tariffs
27.11	Loyalty cards offer genuine savings, says watchdog
27.11	Aston Martin issues second profit warning in two months
27.11	Online slots gambling to be limited to 5 per spin
Consumer Goods and Services »

je.st